K022339

Substantially Equivalent

TOTAL BILIRUBIN

Applicant: Abbott Laboratories
Product code: CIG
Advisory panel: Clinical Chemistry
Date received: 2002-07-18
Decision date: 2002-09-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irving, TX, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.